ECONOMIC EVALUATION OF FEVER MANAGEMENT IN CHILDREN WITH SICKLE CELL DISEASE

镰状细胞病儿童发烧管理的经济评估

• 批准号: 6325929
• 负责人: JEFFREY H SILBER
• 金额: $ 17.18万
• 依托单位: CHILDREN'S HOSP OF PHILADELPHIA
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-04-01 至 2001-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6325929
• 关键词: African American; artificial intelligence; blood toxicology; child (0-11); clinical research; health care cost /financing; health services research tag; hospital utilization; human subject; hyperthermia; patient care management; sickle cell anemia

Great changes are occurring in the financing of health care in America, which are in turn influencing the clinical care of individuals with sickle cell disease (SCD). One great changes has been the use of long acting antibiotics to lower the rate of admission for febrile illness in SCD. The Children's Hospital of Philadelphia has recently instituted a extended stay acute care unit to further attempt to reduce the number of hospitalizations for febrile illness in children with SCD. This project will construct a detailed cost identification model of four alternative approaches to the management of febrile illness in children with SCD. The study will consist of five tasks: (1) To conduct a cost identification study; 92) To estimate patient/family direct and indirect costs associated with a febrile episode in the hospital; (3) To pilot a revised algorithm for the management of febrile illness after analyzing two years of cost data; (4) To perform a second cost identification study using data generated under a revised febrile illness algorithm; and (5) To propose final recommendations regarding the management of febrile illness based on the economic data collected from these studies. This study will analyze results from three different perspectives: the patient/family, the hospital, and society. The project will examine equally efficacious algorithms concerning the prevention of sepsis in SCD. However, since costs to the family may influence compliance with these disease management algorithms, the results of the proposed study may have important medical as well as economic implications. There have been no detailed cost analyses of the alternative approaches to febrile illness in SCD, and especially lacking is any data on the economic impact of these alternative approaches on the family and individual patient. In an era of cost containment, this study should provide fundamental information needed to rationally manage limited resources for this chronically ill population.

美国的医疗保健融资正在发生巨大变化， 这反过来又影响了持镰刀的个人的临床护理 细胞病(SCD)。一个很大的变化是使用了长时间的表演 抗菌药物可降低慢性阻塞性肺疾病发热性疾病入院率。这个 费城儿童医院最近建立了一项延长的 留在急症监护室进一步尝试减少 SCD儿童因发热性疾病住院治疗情况。这个项目 将构建四个备选方案的详细成本识别模型 儿童SCD发热性疾病的处理方法这个 研究将包括五项任务：(1)进行成本识别 研究；估算患者/家庭相关的直接和间接成本 在医院里发烧；(3)试验一种修改后的算法 在分析了两年的成本后，用于发热病的管理 数据；(4)利用数据进行第二次成本识别研究 根据修订的发热病算法生成；以及(5)提出 关于发热性疾病管理的最终建议 从这些研究中收集的经济数据。这项研究将分析 从三个不同的角度得出的结果：患者/家属， 医院和社会。该项目将检验同样有效的 关于SCD脓毒症预防的算法。然而，由于 家庭的费用可能会影响对这些疾病管理的遵守 算法，建议的研究结果可能具有重要的医学意义 以及对经济的影响。目前还没有详细的成本信息 对慢性阻塞性肺疾病发热疾病的替代治疗方法的分析 尤其缺乏关于这些替代方案的经济影响的任何数据。 对家庭和个体患者的处理方法。在一个成本高昂的时代 遏制，这项研究应该提供必要的基本信息 为这群慢性病患者合理管理有限的资源。